Loading...

Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo

Regulatory T cells (T(reg)) are currently being tested in clinical trials as a potential therapy in cell and solid organ transplantation. The immunosuppressive drug rapamycin has been shown to preferentially promote T(reg) expansion. Here, we hypothesized that adjunctive rapamycin therapy might pote...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hester, J, Schiopu, A, Nadig, S N, Wood, K J
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Inc 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440570/
https://ncbi.nlm.nih.gov/pubmed/22500984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2012.04065.x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!